Related Experiment Video
Updated: Nov 15, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea
Arturo Cortés-Telles1, Stephanie López-Romero2, Esperanza Figueroa-Hurtado1
1Respiratory and Thoracic Surgery Unit. Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Calle 7 por 20 y 22 Num. 433, Fraccionamiento Altabrisa, Mérida, Yucatán, 97130, Mexico.
Persistent dyspnoea is common in COVID-19 survivors, indicating true physiological mechanisms. Survivors with persistent shortness of breath show reduced lung function and exercise capacity.
Area of Science:
- Pulmonology
- Infectious Diseases
- Physiology
Background:
- Persistent dyspnoea is a common post-COVID-19 symptom.
- Understanding the physiological underpinnings of long COVID respiratory issues is crucial.
Purpose of the Study:
- To investigate the physiological mechanisms behind persistent dyspnoea in COVID-19 survivors.
- To compare pulmonary function and exercise capacity between COVID-19 survivors with and without persistent dyspnoea.
Main Methods:
- 186 non-critical COVID-19 survivors completed questionnaires and underwent pulmonary function tests and 6-minute walk tests.
- Patients were categorized based on the presence (n=70) or absence (n=116) of persistent dyspnoea.
- Spirometry, diffusing capacity of the lungs for carbon monoxide (DLCO), and exercise testing were performed 30-90 days post-infection.
Main Results:
- Patients with persistent dyspnoea exhibited significantly lower forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and DLCO.
- Reduced 6-minute walk distance and lower end-exercise oxygen saturation were observed in the persistent dyspnoea group.
- Higher self-reported ratings of dyspnoea and fatigue were reported by patients with persistent dyspnoea.
Conclusions:
- Persistent dyspnoea in COVID-19 survivors is associated with measurable physiological impairments.
- Findings suggest spirometric restriction, reduced gas exchange, and decreased functional capacity contribute to post-COVID-19 shortness of breath.
- A true physiological basis likely underlies persistent dyspnoea following COVID-19 infection.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

